RESMED INC — Director's Dealing 2025

Sep 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-09-08

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-08	ResMed Common Stock	M	8009	$101.64	Acquired	475801	Direct
2025-09-08	ResMed Common Stock	S	8009	$278.1359	Disposed	467792	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-08	ResMed Common Stock Options	$101.64	M	8009	Disposed	2025-11-14	ResMed Common Stock (8009)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	2090	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

F2: This transaction was executed in multiple trades at prices ranging from $275.27 - $279.57. The price reported above reflects the weighted average sale price.

F3: Represents date options first become exercisable. Options vest 1/3 per year.